Publications Digest

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Smela et al. analyzed recommendations for systematic literature reviews within the EU Joint Clinical Assessment framework and compared them with established evidence-based medicine standards.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, de Waure et al. presented the conceptual foundation of the European Digital Health Technology Assessment (EDiHTA) framework, developed to support the assessment of digital health technologies across EU member states.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Campione et al. reviewed methods applied in economic evaluations of digital health technologies published between 2020 and 2024.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Konstantinidis et al. reviewed and categorized statistical methods designed for repeated meta-analysis updates in updated and living systematic reviews.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Akpinar et al. developed the DEEM-Q checklist, a consensus-based tool designed to address methodological aspects of economic evaluations that are specific to medical devices.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, D'Souza et al. examined the role of real-world evidence in bridging clinical trials and routine clinical practice.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Grueger et al. explored how HEOR methods can strengthen the implementation of value-based healthcare.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Rylands et al. developed an ISPOR good-practices framework for collecting patient-reported outcomes in real-world studies.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Aballéa et al. critically reviewed the EU HTA Coordination Group guidelines on direct and indirect treatment comparisons in the context of joint clinical assessments.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Bralić et al. conducted a scoping review of methodologies for generating and evaluating evidence for high-risk and innovative medical devices and in vitro diagnostics in the EU.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, de la Cuadra-Grande et al. developed a methodological framework for interpreting indirect treatment comparisons within the European Joint Clinical Assessment process under the Health Technology Assessment Regulation.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Bujkiewicz et al. developed an ISPOR Task Force good-practice report on methods for evaluating surrogate endpoints in health technology assessment decision-making.